Hepatitis B - Global Clinical Trials Review, 2026

Description

List of Tables

GlobalData's clinical trial report, "Hepatitis B - Global Clinical Trials Review, 2026" provides an overview of Hepatitis B Clinical trials scenario. This report provides top line data relating to the clinical trials on Hepatitis B. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma - Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

The report provides a snapshot of the global clinical trials landscape
Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
The Report provides enrollment trends for the past five years
Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to Buy

Assists in formulating key business strategies with regards to investment
Helps in identifying prominent locations for conducting clinical trials which saves time and cost
Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
Supports understanding of trials count and enrollment trends by country in global therapeutics market
Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Product Code: GDHC7328CTIDB

List of Tables

List of Figures

Report Guidance
GlobalData Clinical Trials Report Coverage
Clinical Trials by Region
Clinical Trials and Average Enrollment by Country
Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Five Countries Contributing to Clinical Trials in Middle East and Africa
Top Five Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by G7 Countries: Proportion of Hepatitis B to Infectious Disease Clinical Trials
Clinical Trials by Phase in G7 Countries
Clinical Trials in G7 Countries by Trial Status
Clinical Trials by E7 Countries: Proportion of Hepatitis B to Infectious Disease Clinical Trials
Clinical Trials by Phase in E7 Countries
Clinical Trials in E7 Countries by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Clinical Trials by End Point Status
Subjects Recruited Over a Period of Time
Clinical Trials by Sponsor Type
Prominent Sponsors
Top Companies Participating in Hepatitis B Therapeutics Clinical Trials
Prominent Drugs
Latest Clinical Trials News on Hepatitis B
Feb 23, 2026: Aligos Therapeutics Presents Positive Data On Pevifoscorvir Sodium at the Conference on Retroviruses and Opportunistic Infections (CROI)
Feb 22, 2026: Virion Reports Broad and Sustained Anti-HBV Immunity Following a Single VRON-0200 Dose From its Phase 1b Study at CROI 2026
Feb 02, 2026: Hansoh Pharmaceutical Hengmu: A 5-Year Evidence-Based Collection Recommended by 14 Guidelines and Consensus Reports
Jan 27, 2026: Voluntary Announcement Positive Results From Phase II Trial of TQA3605 "Core Protein Allosteric Modulator" for Chronic Hepatitis B
Jan 21, 2026: Aligos Therapeutics Provides Phase 2 B-Supreme Study Progress Updates
Jan 08, 2026: GSK to file for approval of twice-yearly hep B drug on positive Phase III data
Jan 05, 2026: Voluntary Announcement Announcement on Phase I Clinical Trial of HECN30227 and Progress in the Development of Small Nucleic Acid Platform
Dec 31, 2025: Chengdu Xinzhenghe Pharma's LC-1016 Injection Receives the Clinical Trial Acceptance From NMPA
Dec 23, 2025: AusperBio concludes enrolment in Phase III AUSHINE trial
Dec 12, 2025: AusperBio Announces AHB-137 Monotherapy Achieved 30% Functional Cure Rate in HBe-negative CHB Patients on Stable Nucleos(t)ide Analogue (NA) Therapy
Dec 11, 2025: Aligos Therapeutics Presents Positive Data at HEP-DART 2025
Dec 11, 2025: Karolinska Development's Portfolio Company SVF Vaccines Presents New Preclinical Data Demonstrating Extended Effect of SVF-001 in Hepatitis B and D
Dec 07, 2025: Replicor Publishes Data From its Compassionate Access Program in HBV/HDV
Clinical Trial Profile Snapshots

Appendix

Abbreviations
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Source

Product Code: GDHC7328CTIDB

List of Table

List of Tables

Hepatitis B Therapeutics, Global, Clinical Trials by Region, 2026*
Hepatitis B Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2026*
Hepatitis B Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2026*
Hepatitis B Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2026*
Hepatitis B Therapeutics Clinical Trials, Europe, Top Five Countries, 2026*
Hepatitis B Therapeutics Clinical Trials, North America, Top Countries, 2026*
Hepatitis B Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2026*
Hepatitis B Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2026*
Proportion of Hepatitis B to Infectious Disease Clinical Trials, G7 Countries (%), 2026*
Hepatitis B Therapeutics, G7 Countries, Clinical Trials by Phase, 2026*
Hepatitis B Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2026*
Proportion of Hepatitis B to Infectious Disease Clinical Trials, E7 Countries (%), 2026*
Hepatitis B Therapeutics, E7 Countries, Clinical Trials by Phase, 2026*
Hepatitis B Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2026*
Hepatitis B Therapeutics, Global, Clinical Trials by Phase, 2026*
Hepatitis B Therapeutics, Global, Clinical Trials In Progress by Phase 2026*
Hepatitis B Therapeutics, Global, Clinical Trials by Trial Status, 2026*
Hepatitis B Therapeutics Clinical Trials, Global, by End Point Status, 2026*
Hepatitis B Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2021-2025
Hepatitis B Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2026*
Hepatitis B Therapeutics Clinical Trials, Global, Key Sponsors, 2026*
Hepatitis B Therapeutics Clinical Trials, Global, Top Companies by Phase, 2026*
Hepatitis B Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2026*

List of Figure

List of Figures

Hepatitis B Therapeutics, Global, Clinical Trials by Region (%), 2026*
Hepatitis B Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2026*
Hepatitis B Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2026*
Hepatitis B Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2026*
Hepatitis B Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2026*
Hepatitis B Therapeutics Clinical Trials, North America, Top Countries (%), 2026*
Hepatitis B Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2026*
Hepatitis B Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2026*
Proportion of Hepatitis B to Infectious Disease Clinical Trials, G7 Countries (%), 2026*
Hepatitis B Therapeutics, G7 Countries, Clinical Trials by Phase, 2026*
Hepatitis B Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2026*
Proportion of Hepatitis B to Infectious Disease Clinical Trials, E7 Countries (%), 2026*
Hepatitis B Therapeutics, E7 Countries, Clinical Trials by Phase, 2026*
Hepatitis B Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2026*
Hepatitis B Therapeutics, Global, Clinical Trials by Phase (%), 2026*
Hepatitis B Therapeutics, Global, Clinical Trials In Progress by Phase, 2026*
Hepatitis B Therapeutics, Global, Clinical Trials by Trial Status, 2026*
Hepatitis B Therapeutics Clinical Trials, Global, by End Point Status, 2026*
Hepatitis B Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2021-2025
Hepatitis B Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2026*
Hepatitis B Therapeutics Clinical Trials, Global, Key Sponsors, 2026*
Hepatitis B Therapeutics Clinical Trials, Global, Top Companies by Phase, 2026*
Hepatitis B Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2026*
GlobalData Methodology

Hepatitis B - Global Clinical Trials Review, 2026

Description

Table of Contents

List of Tables

Scope

Reasons to Buy

Table of Contents

Table of Contents

List of Tables

List of Figures

Appendix

List of Table

List of Tables

List of Figure

List of Figures